Lowest Price Guaranteed
Slides
271
Last Updated
September 2025
View Count
12730
The global Mass Spectrometry market is expected to grow from USD 6.4 billion in 2024 to USD 14.6 billion by 2035. The market is anticipated to grow at a CAGR of 7.7% during the forecast period, till 2035.
Mass spectrometry is a significant analytical tool, utilized for identifying and measuring chemical composition in various research industries. The tool is widely used in numerous sectors such as chemistry, biotechnology, medicine, pharmaceutical, environmental studies, and other scientific fields.
Based on the type of product, the global market is bifurcated into instruments and services. The market for instruments is currently the leading segment, holding 78% of the market share. Whereas the service segment is anticipated to contribute notably to the mass spectrometry market growth over this projection period. Mass spectrometry has a variety of instruments that cater to certain applications and their scientific requirements.
 |
These instruments are classified based on their configuration which provides unique features and high performance. The Instrument segment is likely to lead the market due to increased demand for sophisticated analytical tools in research areas such as genomics, proteomics, metabolomics, and pharmaceuticals. For identifying and quantifying molecules, the high sensitivity and specificity of mass spectrometry plays an essential role boosting its demand in these areas and are anticipated to accelerate the market growth. Driven by the growing demand for spectrometers in academic and research institutes, services segment is projected to grow at a higher CAGR of 8.93% during the forecast period.
Based on the purpose of manufacturing, the mass spectrometry market is bifurcated into Scientific Research, Quality Control / Testing, R&D, and OMICS Research. In terms of revenue, OMICS research is anticipated to be a prominent segment in the market over this projection timeframe. This dominance can be ascribed to the surge in demand for mass spectrometry for analyzing molecules in OMICS research. In precision medicine, OMICS relies on mass spectrometry for biomarker identification whereas in drug discovery and development, it benefits the analysis of drug candidates and metabolites.
Based on the type of technology, the market is segmented across hybrid mass spectrometry (Triple quadrupole (Tandem), Quadrupole TOF (Q-TOF), (FT-MS) Fourier Transform Mass Spectrometry), single mass spectrometry (Ion trap, Quadrupole, (TOF) Time of Flight) and others. According to our projection, hybrid mass spectrometry accounts for highest market share (~60%) in 2024. Hybrid mass spectrometers offer higher selectivity, enhanced sensitivity and quantification ability as compared to other mass spectrometers. In hybrid mass spectrometers, triple quadrupole instruments hold the largest share owing to the widespread adoption in pharmaceutical drug discovery, environment monitoring and clinical diagnostics. In terms of growth, fourier transform mass spectrometers are anticipated to grow at a higher CAGR of 8.78% during the forecast period.
This section describes the segmentations based on products manufactured. On the basis of the type of product manufactured, the market is divided into GS-MS, MALDI TOF MS, LC-MS, Quadruple MS, ESI-MS, Ion Trap MS, FT-MS and TOF-MS. In terms of market revenue, Quadruple MS holds the highest mass spectrometry market share and is expected to dominate the market during this forecast period. The growing need for Quadruple MS in the pharmaceutical industry due to its capacity to quantify a wide range of compounds with minimum sample preparation is ascribed to augment the growth of the segment in the coming years.
Based on the type of application area, the global mass spectrometry market is segmented into proteomics, metabolomics, glycomics and others. According to our projection, proteomics market segment currently accounts for the largest share (46%). Mass spectrometers have been widely used in pharmaceutical and research institutes for quantitative analysis of proteins. The technology also helps to understand the protein-protein interactions, which becomes a primary reason of adoption of mass spectrometers on a large scale. Metabolomics is the fastest growing segment during the forecast period owing to the growing usage of mass spectrometers in cancer screening and disease diagnosing at molecular level.
Based on the end user, the global mass spectrometry market is bifurcated into pharmaceutical companies, biotechnology companies, research labs and academic institutes, environment testing industry, food & beverage industry, forensic, petrochemical industry and other end users. In terms of market revenue, pharmaceutical companies account for holding the largest share (23%) of the market. Pharmaceutical companies are emphasizing the development of personalized medicine to treat patients’ individual requirements.
Mass spectrometers play an essential role in measuring metabolites, specific biomarkers and drug compounds within biological samples collected from patient body, thereby facilitating the development of personalized medicine. Driven by the growing research on advance drugs and therapies, research labs and academic institutes account to hold highest share and is poised to grow at a higher CAGR of 8.02% during the forecast period. Researchers require advanced mass spectrometers to identify the targeted drug molecules, which is anticipated to drive the demand for mass spectrometers during the forecast period.
Based on the company size, the mass spectrometry market is split into small, mid-sized, large, and very large companies. Presently, the market is led by very large and large companies and is expected to continue to lead throughout the forecast period. Prominent companies and their competitive strategies, strong product portfolio, adoption of advanced technologies, high investment in R&D for innovative products, and customer-centric approach are ascribed to their market dominance.
This segment shows the distribution of the global market across various geographies, such as North America, Europe, and Asia-Pacific Latin America, Middle East and North Africa. According to our projections, North America has been a leading region in the market and accounts for 40% of the mass spectrometry market share over this forecast period. The well-established pharmaceutical industry in the region has significantly spiked the demand for mass spectrometry as pharmaceutical companies and research laboratories require reliable and efficient instruments for accurate data analysis in drug discovery, drug detection, and precise chemical composition. In addition, robust end user applications such as food, biochemical, forensic science, and environment testing are further likely to boost the market growth. North America’s stringent environmental regulations and strict standards of food safety are also expected to accelerate the growth of the market in the region.
Asia Pacific is one of the fastest-growing regions for mass spectrometry with a rapidly growing healthcare sector, expanding industrialization, rising pharmaceuticals, research institutions, and increasing emphasis on environmental sustainability. Due to these factors, Asia Pacific is projected to influence the mass spectrometry market growth with 8.97% CAGR over the forecast, till 2035.
The “Mass Spectrometry Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the companies involved in the mass spectrometry industry. The market report highlights the efforts of several instrument manufacturers and service providers engaged in this rapidly emerging segment of the medical device industry. Key takeaways of the market analysis are briefly discussed below.
Numerous small and big size companies are operating in the mass spectrometry market. By leveraging their expertise, and capabilities of their advanced instruments, these companies are changing the market dynamics. The major instrument manufacturing companies such as Waters, Perkin Elmer, Inc. Bruker, Thermo Fisher Scientific, and others provide GS-MS, MALDI, TOFMS, LC-MS, Quadruple MS, and ESI types of instruments.
These key players engage in collaboration and partnership with other market players and end-user industries which aid them to expand their market reach. They also focus on high capital investment in research and development programs to develop cutting-edge-technology to offer a broader range of products. For instance, in June 2023, Bruker launched the unique triple-quad (TQ) mass spectrometer EV OQ DART-TQ, featuring the first and only fully integrated DART (Direct Analysis in Real Time) ionization source that eliminates complex and time-consuming gas or liquid chromatography for many point-of-need routine workflows.
One of the significant drivers of mass spectrometry market growth is the growing demand for advanced quantitative analysis tools for drug discovery and development. Mass spectrometers play a significant role in the analysis of drug molecules, allowing researchers to identify and characterize innovative drug candidates. Moreover, these spectrometers also play an extensive role in determining the efficacy and efficiency of drugs, which becomes a primitive reason of growing demand for mass spectrometers in drug discovery. Additionally, the growing technological innovations in spectrometers for high resolution testing with precision is further driving the market during the forecast period.
The market for mass spectrometry faced challenges during the COVID-19 pandemic which caused disruptions in the global supply chain due to lockdown restrictions on the entire business and industrial operations. The sudden outbreak of the coronavirus halted the market demand owing to the shutdown of the chemical and manufacturing industries in the year 2021-2022. However, the market began to gain momentum after the ease of limitation and is expected to overcome the previous year’s deficit in the mass spectrometry market forecast.
In recent years, the mass spectrometry market has been evolving with several emerging trends that are shifting the market dynamics. Continuous advancements in mass spectrometry technology is one such trend, reflecting the changing requirements and shifting research preferences. With the ongoing advancements, manufacturers are developing miniaturized and portable mass spectrometry instruments integrated with hybrid technology to fulfill the requirement for on-site and point of care testing in end-user industries like food safety, clinical diagnostics, environmental testing, and forensic analysis. Additionally, continuous development in ionization techniques boosts the potential of mass spectrometry tools. These techniques can be ambient ionization, laser ablation, and novel ion sources.
Apart from this, prominent manufacturers are increasing their collaboration and acquisition with other companies to expand their product portfolio. In June 2022, Thermo Fisher Scientific declared its plans to extend its partnership with Symphogen (a biotechnology company based in Denmark) with an intention to offer simplified workflows and enhanced monitoring quality of complex therapeutics proteins by leveraging the Thermo Scientific Q EXactive Plus Orbitrap LC-MS/MS System.
The market for mass spectrometry is experiencing a tremendous demand for hybrid and high-resolution instruments. These hybrid instruments are integrated with multiple mass analyzers, for instance, quadrupole-TOF, quadrupole-Orbitrap, and quadrupole-ion trap configurations. These instruments are gaining traction due to their versatility, resolution, and sensitivity which provide accurate and efficient analyses to researchers. Leading manufacturers are offering these instruments with advanced hybrid technology to fulfill the rising demand for hybrid and high-resolution tools in the market.
The global market for mass spectrometry (including instruments and services market) is currently estimated to be worth USD 6.4 billion. Driven by the growing adoption of mass spectrometry in pharmaceutical companies and research institutes, the market growth is expected to increase at a CAGR of 7.7% over the forecast period.
It is worth highlighting that, in terms of type of product, instruments are expected to capture the majority of the mass spectrometry market share during the forecast period. This can be attributed to the escalating research and development programs around the world, and growing drug discovery in the pharmaceutical industry. The expansion of the biotechnology industry is also expected to accelerate the demand for mass spectrometry among diverse application industries.
According to market research, North America accounts for more than one-third of the overall mass spectrometry market size. Several factors such as the presence of key players in the region including Thermo Fisher, Agilent Technologies, and Waters Corporations that hold notable market shares, is stimulating the market growth. As well as early adoption of advanced technology, and rising government investments in research and development projects are attributed to the region’s dominance in the global market.
Moreover, the Asia Pacific region also plays a crucial role in the market demand due to its fastest growing economy and rapid industrialization in emerging nations. Also, the increasing government funding and investment for research and development activities in the region is projected to fuel the mass spectrometry market growth with a substantial CAGR during this forecast period.
Examples of key companies engaged in the mass spectrometry industry (which have also been profiled in this market report; the complete list of companies is available in the full report) include Agilent Technologies, AMETEK Process Instruments, Advion, Analytik Jena, Bruker Corporation, DANI Instruments, FLIR Systems, Extrel CMS, Hiden Analyticals, JEOL, Kore Technology, LECO, MassTech, MKS Instruments, PerkinElmer, Rigaku, SCIEX, Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation. This market report includes an easily searchable excel database of all the companies who are developing mass spectrometers or providing services.
The market research report presents an in-depth analysis of the various companies that are engaged in the global market of mass spectrometry, across different segments, as defined in the table below:
| Key Report Attributes | Details | |
| Historical Trend | Since 2018 | |
| Forecast Period | 10+ Years | |
| Future Trend | Till 2035 | |
| Market Size Value by 2035 | USD 14.6 billion | |
| Growth Rate | ~7.7% | |
| Type of Product |
|
|
| Purpose of Manufacturing |
|
|
| Type of Technology |
|
|
| Type of Product Manufactured |
|
|
| Type of Application Area |
|
|
| Company Size |
|
|
| End Users |
|
|
| Key Geographical Regions |
|
|
| Key Companies Profiled |
(Full list of operating companies captured is available in the report) |
|
| PowerPoint Presentation (Complimentary) | Available | |
| Customization Scope | 15% Free Customization | |
|
Excel Data Packs |
|
|
One of the key objectives of this market report was to estimate the current market size, opportunity and the future growth potential of the mass spectrometry market, over the forecast period. Based on multiple parameters, likely adoption trends, and through primary validations, we have provided an informed estimate of the market evolution during the forecast period 2023-2035. The market report also features the likely distribution of the current and forecasted opportunity across various segments, such as type of mass spectrometry (Instrument and Service), purpose of manufacturing (Scientific Research, Quality Control / Testing, R&D), type of technology (hybrid mass spectrometry, single mass spectrometry and others), type of product manufactured (GS-MS, MALDI, TOFMS, LC-MS, Quadruple MS, ESI-MS, Ion Trap MS), company size (small, mid-sized, large and very large), end user (pharmaceutical companies, biotechnology companies, research labs and academic institutes, environment testing industry, food & beverage industry, forensic, petrochemical industry and other end users) and key geographical regions (North America, Europe and Asia Pacific, Middle East and North Africa). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
In recent years, the market for mass spectrometry has witnessed a significant number of developments. These developments, even if they took place post the release of our market report, substantiate the overall trends that have been outlined in our market analysis.